[시장보고서]세계의 실험실 자동화 시장 : 제품별, 용도별, 최종 사용자별, 지역별

세계의 실험실 자동화 시장 : 제품별, 용도별, 최종 사용자별, 지역별 - 예측(-2029년)

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2029

상품코드 : 1623606 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2024년 12월

페이지 정보 : 영문 412 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,151,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,607,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,775,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,448,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 실험실 자동화 시장 규모는 2024년 58억 5,000만 달러에서 2029년 77억 1,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 6.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

실험실 자동화 솔루션의 주요 촉진요인으로는 높은 처리량 검사의 필요성, 오믹스 연구 증가, 실험실 절차에서 보다 정확하고 빠른 결과의 필요성 등이 있습니다. 또한, 만성 질환의 유병률 증가는 연구 개발에 대한 지출을 요구하고 더 빠른 진단의 필요성을 가져와 자동화 채택을 증가시킬 것입니다.

조사 범위
조사 대상년도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
검토 단위	금액(미화)
부문별	제품별, 용도별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동/아프리카

예측 기간 동안 자동 워크스테이션 분야가 실험실 자동화 시장을 주도할 것으로 보입니다. 이 제품군은 간소화된 워크스테이션, 향상된 정확도, 다양한 응용 분야에 걸친 반복성을 통해 실험실 워크플로우를 최적화하는 데 도움을 줍니다. 자동화 워크스테이션 제품의 경우, 액체 취급 워크스테이션 제품은 현재 PCR, qPCR, 차세대 시퀀싱 등 다양한 응용 분야에 필수적인 시료 및 시약의 고정밀 이송에 가장 많이 사용되고 있습니다. 또 다른 주요 하위 부문은 마이크로플레이트 리더기입니다. 분석에서 높은 처리량의 스크리닝 및 정량화를 가능하게 하여 신약 개발 및 생물학적 연구 속도를 크게 높일 수 있습니다. 자동 ELISA 시스템은 면역 측정에 시간이 많이 걸리는 프로토콜을 자동화하기 때문에 높은 수요가 있습니다. 자동 ELISA 시스템은 모든 면역 측정 프로토콜을 수행하기 때문에 진단 및 임상 검사에 소요되는 시간을 크게 단축하고 출력이 빠르고 신뢰할 수 있으며 수동 입력의 개입을 최소화 할 수 있습니다. 이와는 별도로, 자동 핵산 정제 시스템은 분자 생물학 및 유전체 연구에서 DNA 및 RNA 추출 및 정제 과정을 가속화하고 추가 응용을 위해 필요한 것으로 간주됩니다. 이러한 하위 부문에 대한 조사는 효율성과 데이터 품질 향상에 대한 실험실 자동화 시장의 관심을 보여줍니다.

실험실 자동화 시장의 최종 사용자별 시장은 병원 및 진단 실험실, 제약 및 생명 공학 기업, 연구 및 학술 기관, 환경 테스트 실험실, 법의학 실험실, 식음료 산업으로 세분화되며, 2023년 가장 큰 점유율을 차지할 것으로 예상되는 분야는 병원 및 진단 실험실입니다. 이는 주로 다양한 복잡한 검사를 필요로 하는 많은 환자를 치료하기 위해 처리량, 정확도 및 빠른 진단 솔루션에 대한 수요가 증가하고 있기 때문입니다. 이는 자동화 솔루션이 워크플로우를 간소화하고, 처리 시간을 최소화하며, 정확도를 향상시킬 수 있도록 하기 위함입니다.

아시아태평양은 예측 기간 동안 실험실 자동화 시장에서 가장 높은 성장률을 보이며 성장을 주도할 것으로 예상됩니다. 이는 헬스케어 인프라에 대한 투자 증가, 제약 및 생명공학 산업의 연구개발에 대한 집중, 이 지역의 인구 증가에 따른 효율적인 진단 솔루션에 대한 수요 증가에 기인합니다. 또한, 인공지능과 로봇 공학의 발전은 다른 부문의 실험실 자동화를 돕고 있습니다.

이 보고서는 세계의 실험실 자동화 시장을 조사했으며, 제품별/용도별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리한 보고서입니다.

서론
시장 역학
기술 분석
공급망 분석
밸류체인 분석
Porter의 Five Forces 분석
주요 이해관계자와 구입 기준
특허 분석
주요 컨퍼런스 및 이벤트
무역 데이터 분석
미충족 요구와 주요 문제점
생태계 분석
고객의 비즈니스에 영향을 미치는 동향/혼란
투자와 자금조달 시나리오
실험실 자동화 시장 생성형 AI의 영향
규제 상황
가격 분석

제6장 실험실 자동화 시장, 제품별

서론
자동화 워크스테이션
기제 자동화 작업 셀
소프트웨어
로봇 시스템
자동 보관 및 회수 시스템
기타

제7장 실험실 자동화 시장, 용도별

서론
Drug Discovery
진단
유전체학
단백질체학
미생물학
기타

제8장 실험실 자동화 시장, 최종사용자별

서론
바이오테크놀러지 기업 및 제약회사
병원 및 진단실험실
연구 및 학술기관
환경 시험 연구소
법의학 연구소
식품 및 음료 업계

제9장 실험실 자동화 시장, 지역별

서론
북미
- 북미 : 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽 : 거시경제 전망
- 독일
- 프랑스
- 영국
- 이탈리아
- 스위스
- 네덜란드
- 기타
아시아태평양
- 아시아태평양 : 거시경제 전망
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 라틴아메리카 : 거시경제 전망
- 브라질
- 멕시코
- 기타
중동 및 아프리카
- 중동 및 아프리카 : 거시경제 전망
- GCC 국가
- 기타

제10장 경쟁 구도

개요
주요 시장 진출기업의 전략/강점
매출 분석, 2020년-2023년
시장 점유율 분석, 2023년
기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
기업 평가 매트릭스 : 스타트업/중소기업, 2023년
기업 가치 평가와 재무 지표
제품/브랜드 비교
경쟁 시나리오

제11장 기업 개요

주요 시장 진출기업
- THERMO FISHER SCIENTIFIC INC.
- TECAN TRADING AG
- DANAHER CORPORATION
- AGILENT TECHNOLOGIES
- F. HOFFMANN-LA ROCHE LTD.
- METTLER TOLEDO
- REVVITY, INC.
- EPPENDORF SE
- BECTON, DICKINSON AND COMPANY
- WATERS CORPORATION
- SIEMENS HEALTHINEERS
- ABBOTT LABORATORIES
- BIOMERIEUX
- HAMILTON COMPANY
- HUDSON ROBOTICS
기타 기업
- GILSON, INC.
- BMG LABTECH
- FESTO AG & CO. KG
- AURORA BIOMED INC.
- HIGHRES BIOSOLUTIONS
- OPENTRONS LABWORKS INC.
- PEAK ANALYSIS AND AUTOMATION
- QIAGEN N.V.
- LABVANTAGE SOLUTIONS, INC.
- BIO-RAD LABORATORIES, INC.
- LABWARE
- SYSMEX CORPORATION
- UNIVERSAL ROBOTS
- AB CONTROLS, INC.
- AUTOMATA
- SPT LABTECH
- BIOSERO, INC.

제12장 부록

LSH

영문 목차

영문목차

The global lab automation market is projected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at a CAGR of 6.9% during the forecast period. Some of the primary drivers for the lab automation solutions include the need for high-throughput testing, an increase in omics research, and the need for more precise and faster results in laboratory procedures. Moreover, an increase in the prevalence of chronic diseases necessitates expenditure in research and development and need for faster diagnosis, which increases the adoption of automation.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	By Product, Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"Automated Workstation to register largest market share in 2023"

The automated workstation segment will lead the lab automation market during the forecast period. This product line helps optimize the laboratory workflow through streamlined workstations, and increased precision, and reproducibility across many applications. In the case of the automated workstation product, liquid-handling workstation products are currently most commonly used for high-accuracy transfer of samples and reagents that are vital in a variety of applications involving PCR, qPCR, next-generation sequencing, etc. Another major sub-segment is microplate readers. It enables high-throughput screening and quantification in assays, thus significantly speeding up drug discovery and biological research. Automated ELISA systems are in high demand because they automate the protocols that take time to run through immunoassays. Automated ELISA systems save diagnostics and clinical laboratories lots of time because it does all the immunoassay protocols, hence the output is rapid and reliable, minimizing the involvement of manual inputs. Apart from that, automated nucleic acid purification systems are considered necessary for molecular biology and genomics research to speed up DNA and RNA extraction and purification processes for further applications. Growth in these sub-segments is indicative of the interest of the lab automation market toward increasing efficiency and data quality, which are now crucial factors in all pharmaceutical, diagnostic, and research settings.

"Hospitals & diagnostic laboratories segment held the largest share of Lab Automation market in 2023, by End-user."

The market by end-users of the lab automation market is further divided into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research and academic institutes, environmental testing laboratories, forensic laboratories, and the food and beverage industry. The largest share in 2023 would be hospitals and diagnostic laboratories mainly due to increasing demand for throughput, accuracy, and high-speed diagnostics solutions to treat more patients requiring a variety of complex tests. This will ensure automation solutions simplify workflows, minimize turnaround times, and improve accuracy.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia Pacific region will be the leader in growth in the lab automation market, with the highest rate during the forecast period. It will be driven by increased investment in healthcare infrastructure, research and development emphasis by the pharmaceutical and biotechnology industries, and increased demand for efficient diagnostic solutions for this region's increasing population. In addition, developments in artificial intelligence and robotics are assisting the laboratories within other sectors to become more automated.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
By Designation: C-level-- 10%, Director-level-14%, and Others-76%
By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the world-8%

Prominent players in the Lab Automation market include: Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

Research Coverage

The market is categorized by the product, application, end-user, and region. Factors affecting the lab automation market-including drivers, restraints, opportunities, and challenges are also discussed in the report. The report provides a perspective of opportunities and challenges ahead for stakeholders, besides profiling the details of leading players' competitive landscape. The micro-markets are further segregated by focusing on growth trends, prospects, and contributions of these trends to the lab automation market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.

Key Benefits of Buying this Report

This report is to be benefitted by new and existing players. It will give deep information about the lab automation market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Owing to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas. Further, this report supplies critical trends, challenges, growth drivers, and opportunities that complete the strategic decision-making process with a well-balanced analysis.

Through this report, readers get insightful views into the following parameters:

Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for lab automation market. The major driving forces behind lab automation market are an increase in chronic diseases. Requirement for rapid and precise diagnostic tools enhances demand for automation solutions. Technologically, the development of rapid and automated testing systems supports market growth by increasing efficiency and accuracy in tests.

Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.

Market Development: Further, the report has elaborated the markets by segmenting the lab automation market into different regions

Market Diversification: New product launches, unexploited markets, recent developments, investments in the lab automation market.

Competitive Analysis: Exhaustive study of market share, service offering leading strategies of major players such as Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.4 MARKET SCOPE
- 1.4.1 MARKETS COVERED
- 1.4.2 YEARS CONSIDERED
- 1.4.3 CURRENCY CONSIDERED
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 ADDITION OF IMPACT OF GENERATIVE AI

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
2.2 RESEARCH DATA
2.3 RESEARCH DESIGN
- 2.3.1 SECONDARY RESEARCH
  - 2.3.1.1 Key data from secondary sources
- 2.3.2 PRIMARY RESEARCH
  - 2.3.2.1 Primary sources
  - 2.3.2.2 Key industry insights
2.4 MARKET SIZE ESTIMATION
- 2.4.1 BOTTOM-UP APPROACH
  - 2.4.1.1 Approach 1: Company revenue estimation approach
  - 2.4.1.2 Approach 2: Customer-based market estimation
- 2.4.2 TOP-DOWN APPROACH
  - 2.4.2.1 Approach 3: Top-down approach
  - 2.4.2.2 Approach 4: Primary interviews
2.5 GROWTH FORECAST
2.6 DATA TRIANGULATION
2.7 MARKET SHARE ASSESSMENT
2.8 RESEARCH ASSUMPTIONS
2.9 RESEARCH LIMITATIONS
- 2.9.1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 LAB AUTOMATION MARKET OVERVIEW
4.2 LAB AUTOMATION MARKET, BY REGION
4.3 ASIA PACIFIC: LAB AUTOMATION MARKET, BY COUNTRY AND END USER
4.4 GEOGRAPHIC SNAPSHOT OF LAB AUTOMATION MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Need for automation in drug discovery
  - 5.2.1.2 Advancements in artificial intelligence and robotics
  - 5.2.1.3 Growth in demand for process automation for food safety
  - 5.2.1.4 Rise in demand for automation in forensics
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High initial investment costs
  - 5.2.2.2 Slow adoption in developing regions
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increased expenditure on healthcare
  - 5.2.3.2 Growth in pharmaceutical and biotechnology industries
- 5.2.4 CHALLENGES
  - 5.2.4.1 System integration issues
  - 5.2.4.2 Availability of refurbished lab automation equipment
5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
  - 5.3.1.1 Cobots
  - 5.3.1.2 Biobanking
  - 5.3.1.3 High-throughput screening (HTS) technologies
- 5.3.2 COMPLEMENTARY TECHNOLOGIES
  - 5.3.2.1 Cloud connectivity
  - 5.3.2.2 Internet of Things (IoT)
  - 5.3.2.3 Digital twins
- 5.3.3 ADJACENT TECHNOLOGIES
  - 5.3.3.1 MICROFLUIDICS TECHNOLOGY
5.4 SUPPLY CHAIN ANALYSIS
- 5.4.1 PROMINENT COMPANIES
- 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
- 5.4.3 END USERS
5.5 VALUE CHAIN ANALYSIS
- 5.5.1 RESEARCH & DEVELOPMENT
- 5.5.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
- 5.5.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.6 PORTER'S FIVE FORCES ANALYSIS
- 5.6.1 THREAT OF NEW ENTRANTS
- 5.6.2 THREAT OF SUBSTITUTES
- 5.6.3 BARGAINING POWER OF SUPPLIERS
- 5.6.4 BARGAINING POWER OF BUYERS
- 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.7.2 KEY BUYING CRITERIA
5.8 PATENT ANALYSIS
- 5.8.1 LIST OF MAJOR PATENTS
5.9 KEY CONFERENCES AND EVENTS
5.10 TRADE DATA ANALYSIS
- 5.10.1 IMPORT DATA (HS CODE 8479)
- 5.10.2 EXPORT DATA (HS CODE 8479)
5.11 UNMET NEEDS AND KEY PAIN POINTS
5.12 ECOSYSTEM ANALYSIS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.14 INVESTMENT AND FUNDING SCENARIO
5.15 IMPACT OF GEN AI ON LAB AUTOMATION MARKET
5.16 REGULATORY LANDSCAPE
- 5.16.1 REGULATORY STANDARDS AND APPROVALS
  - 5.16.1.1 North America
    - 5.16.1.1.1 US
    - 5.16.1.1.2 Canada
  - 5.16.1.2 Europe
  - 5.16.1.3 Asia Pacific
    - 5.16.1.3.1 Japan
    - 5.16.1.3.2 China
    - 5.16.1.3.3 India
- 5.16.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.17 PRICING ANALYSIS
- 5.17.1 AVERAGE SELLING PRICE TREND, BY REGION
- 5.17.2 AVERAGE SELLING PRICE OF ROBOTIC ARMS, BY KEY PLAYER

6 LAB AUTOMATION MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 AUTOMATED WORKSTATIONS
- 6.2.1 AUTOMATED LIQUID HANDLING SYSTEMS
  - 6.2.1.1 Automated integrated workstations
    - 6.2.1.1.1 Preference for modular, integrated workstations over standalone systems
  - 6.2.1.2 Pipetting systems
    - 6.2.1.2.1 Substantial progress in developing accurate robotic pipetting systems
  - 6.2.1.3 Reagent dispensers
    - 6.2.1.3.1 Adoption of advanced technologies for dispensing minute volumes by prominent players
  - 6.2.1.4 Microplate washers
    - 6.2.1.4.1 Multiple customizable benefits provided by microplate washers
- 6.2.2 MICROPLATE READERS
  - 6.2.2.1 Multi-mode microplate readers
    - 6.2.2.1.1 Filter-based readers
      - 6.2.2.1.1.1 High sensitivity and high specificity to enhance product demand
    - 6.2.2.1.2 Monochromator-based readers
      - 6.2.2.1.2.1 Greater flexibility and enhanced sensitivity among benefits
    - 6.2.2.1.3 Hybrid readers
      - 6.2.2.1.3.1 Combined benefits of filter- and monochromator-based readers such as high flexibility, sensitivity, and convenience to laboratories
  - 6.2.2.2 Single-mode microplate readers
    - 6.2.2.2.1 Fluorescence readers
      - 6.2.2.2.1.1 Integration of AI and machine learning to enhance data analysis and interpretation
    - 6.2.2.2.2 Absorbance readers
      - 6.2.2.2.2.1 Emerging trends emphasize boosting throughput through automation and integration with robotic systems
    - 6.2.2.2.3 Luminescence readers
      - 6.2.2.2.3.1 Greater sensitivity than absorbance and fluorescence readers
- 6.2.3 AUTOMATED ELISA SYSTEMS
  - 6.2.3.1 Greater role of immunoassays in testing with increase in incidence of chronic and infectious diseases
- 6.2.4 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS
  - 6.2.4.1 Wide applications of automated nucleic acid extraction systems
6.3 OFF-THE-SHELF AUTOMATED WORK CELLS
- 6.3.1 PRE-ANALYTICAL AUTOMATION
  - 6.3.1.1 Consistent and accurate sample preparation with efficiency, enhancing quality of subsequent analyses
- 6.3.2 POST-ANALYTICAL AUTOMATION
  - 6.3.2.1 Automation of data processing, results verification, and sample handling after analysis to save time and minimize human errors
- 6.3.3 TOTAL LAB AUTOMATION
  - 6.3.3.1 Despite its advantages, total lab automation remains challenging to implement in most labs
6.4 SOFTWARE
- 6.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEMS
  - 6.4.1.1 Minimizing human errors and consolidating access and storage of quality control data
- 6.4.2 ELECTRONIC LABORATORY NOTEBOOKS
  - 6.4.2.1 Data security and user-friendly interface to store and use electronic records
- 6.4.3 LABORATORY EXECUTION SYSTEMS
  - 6.4.3.1 Paperless, high-productivity environment to optimize workflows
- 6.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS
  - 6.4.4.1 Securely managing consolidated scientific data generated from various laboratory instruments
6.5 ROBOTIC SYSTEMS
- 6.5.1 ROBOTIC ARMS
  - 6.5.1.1 Flexibility, accuracy, and enhanced to increase application of robotic arms
- 6.5.2 TRACK ROBOTS
  - 6.5.2.1 Innovative, customizable products offered by key players to streamline workflows
- 6.5.3 COLLABORATIVE ROBOTS
  - 6.5.3.1 Rapidly expanding robotics technology with significant market potential
- 6.5.4 MOBILE ROBOTS
  - 6.5.4.1 Significant technological trends and integration with software to minimize manual handling
6.6 AUTOMATED STORAGE & RETRIEVAL SYSTEMS
- 6.6.1 EFFICIENT COLLECTION AND HANDLING OF CHEMICALS AND BIOLOGICS ESSENTIAL IN DRUG DISCOVERY
6.7 OTHER LAB AUTOMATION EQUIPMENT

7 LAB AUTOMATION MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 DRUG DISCOVERY
- 7.2.1 ACCELERATION OF DRUG DEVELOPMENT TIMELINE THROUGH FULLY AUTOMATED, ULTRA-HIGH-THROUGHPUT SYSTEMS
- 7.2.2 HIGH-THROUGHPUT SCREENING
  - 7.2.2.1 Integrating automation technologies with high-throughput screening to rapidly identify compounds
- 7.2.3 COMPOUND MANAGEMENT
  - 7.2.3.1 Prominent players offering automated compound management systems that support growth
- 7.2.4 ADME SCREENING
  - 7.2.4.1 Growth in requirement for ADME screening in drug discovery
- 7.2.5 COMPOUND WEIGHING & DISSOLUTION
  - 7.2.5.1 Potential of automation to improve precision and operational efficiency without user intervention
- 7.2.6 OTHER DRUG DISCOVERY APPLICATIONS
7.3 DIAGNOSTICS
- 7.3.1 RISE IN IMPORTANCE OF AUTOMATION IN DIAGNOSTIC PRECISION AND EFFICIENCY
- 7.3.2 PRE-ANALYTICS/SAMPLE PREPARATION
  - 7.3.2.1 Minimizing errors and labor costs while enhancing precision and productivity
- 7.3.3 ENZYME IMMUNOASSAYS
  - 7.3.3.1 Rise in demand for automation of critical EIA processes with growing global burden of target diseases
- 7.3.4 SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING
  - 7.3.4.1 Ease of monitoring interaction and need for reduced tube manipulation
7.4 GENOMICS
- 7.4.1 ANALYSIS OF HIGHER VOLUME OF VITAL DATA WITH ADVANCEMENTS IN NEXT-GENERATION SEQUENCING
7.5 PROTEOMICS
- 7.5.1 NEED FOR ROBOTICS TO REDUCE COMPLEXITY OF PROTEOME DATASETS
7.6 MICROBIOLOGY
- 7.6.1 INCREASE IN PRECISION AND EFFICIENCY SUPPORT DEMAND FOR AUTOMATION IN MICROBIOLOGY WORKFLOWS
7.7 OTHER APPLICATIONS

8 LAB AUTOMATION MARKET, BY END USER

8.1 INTRODUCTION
8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
- 8.2.1 BIOTECH & PHARMA COMPANIES: MAJOR END USERS OF AUTOMATION
8.3 HOSPITAL & DIAGNOSTIC LABORATORIES
- 8.3.1 AUTOMATION TO MEET DEMAND FOR FAST AND PRECISE RESULTS IN HOSPITALS & DIAGNOSTICS
8.4 RESEARCH & ACADEMIC INSTITUTES
- 8.4.1 INCREASE IN BIOTECHNOLOGY AND LIFE SCIENCE RESEARCH
8.5 ENVIRONMENTAL TESTING LABORATORIES
- 8.5.1 INTEGRATING AUTOMATION IN LABS TO ENHANCE EFFICIENCY OF SAMPLE PROCESSING, PREPARATION, AND TESTING
8.6 FORENSIC LABORATORIES
- 8.6.1 PROMINENT COMPANIES TO ADOPT AUTOMATION FOR BETTER OUTCOMES WITH SUPPORT EVIDENCE ANALYSIS AND ENABLE INNOVATIVE FORENSIC TECHNIQUES
8.7 FOOD & BEVERAGE INDUSTRY
- 8.7.1 INCREASE IN UTILIZATION OF ROBOTIC ARMS IN FOOD & BEVERAGE INDUSTRY

9 LAB AUTOMATION MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
- 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 9.2.2 US
  - 9.2.2.1 Availability of research funding and increasing pace of metabolomics research
- 9.2.3 CANADA
  - 9.2.3.1 Innovative products related to automation with increase in focus and presence of key players
9.3 EUROPE
- 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 9.3.2 GERMANY
  - 9.3.2.1 Presence of public & private organizations with focus on R&D
- 9.3.3 FRANCE
  - 9.3.3.1 Rise in investments by pharma and biotech companies in R&D infrastructure and genomic research aimed at personalized therapeutics
- 9.3.4 UK
  - 9.3.4.1 Early-stage research in new drugs and vaccines, with increased government funding in healthcare
- 9.3.5 ITALY
  - 9.3.5.1 Biotechnology advancements and R&D investments drive market growth
- 9.3.6 SWITZERLAND
  - 9.3.6.1 Strong player in precision manufacturing and industry 4.0
- 9.3.7 NETHERLANDS
  - 9.3.7.1 Leader in R&D for lab automation solutions with various funding sources
- 9.3.8 REST OF EUROPE
9.4 ASIA PACIFIC
- 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 9.4.2 CHINA
  - 9.4.2.1 Advanced automation solutions brought by key players
- 9.4.3 JAPAN
  - 9.4.3.1 Strategic partnerships and expansions, with focus on healthcare of older people
- 9.4.4 INDIA
  - 9.4.4.1 Automation technology gaining traction in Indian clinics and hospitals
- 9.4.5 AUSTRALIA
  - 9.4.5.1 Increase in spending on healthcare and genomic research
- 9.4.6 SOUTH KOREA
  - 9.4.6.1 Application of automation in microbiology and food & beverage sector
- 9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
- 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 9.5.2 BRAZIL
  - 9.5.2.1 Rise in public and private initiatives and support for scientific research
- 9.5.3 MEXICO
  - 9.5.3.1 Favorable business environment for market players
- 9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
- 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
- 9.6.2 GCC COUNTRIES
  - 9.6.2.1 Advancements in healthcare infrastructure and innovation
- 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.3 REVENUE ANALYSIS, 2020-2023
10.4 MARKET SHARE ANALYSIS, 2023
- 10.4.1 RANKING OF KEY MARKET PLAYERS
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 10.5.1 STARS
- 10.5.2 EMERGING LEADERS
- 10.5.3 PERVASIVE PLAYERS
- 10.5.4 PARTICIPANTS
- 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 10.5.5.1 Company footprint
  - 10.5.5.2 Product footprint
  - 10.5.5.3 Application footprint
  - 10.5.5.4 End user footprint
  - 10.5.5.5 Region footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 10.6.1 PROGRESSIVE COMPANIES
- 10.6.2 RESPONSIVE COMPANIES
- 10.6.3 DYNAMIC COMPANIES
- 10.6.4 STARTING BLOCKS
- 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
  - 10.6.5.1 Detailed list of key startup/Sme players, 2023
  - 10.6.5.2 Competitive benchmarking of key emerging players/startups
10.7 COMPANY VALUATION AND FINANCIAL METRICS
10.8 PRODUCT/BRAND COMPARISON
10.9 COMPETITIVE SCENARIO
- 10.9.1 PRODUCT LAUNCHES AND APPROVALS
- 10.9.2 DEALS
- 10.9.3 EXPANSION

11 COMPANY PROFILES

11.1 KEY PLAYERS
- 11.1.1 THERMO FISHER SCIENTIFIC INC.
  - 11.1.1.1 Business overview
  - 11.1.1.2 Products offered
  - 11.1.1.3 Recent developments
    - 11.1.1.3.1 Product launches and approvals
    - 11.1.1.3.2 Deals
    - 11.1.1.3.3 Expansions
  - 11.1.1.4 MnM view
    - 11.1.1.4.1 Right to win
    - 11.1.1.4.2 Strategic choices
    - 11.1.1.4.3 Weaknesses and competitive threats
- 11.1.2 TECAN TRADING AG
  - 11.1.2.1 Business overview
  - 11.1.2.2 Products offered
  - 11.1.2.3 Recent developments
    - 11.1.2.3.1 Product launches
    - 11.1.2.3.2 Deals
  - 11.1.2.4 MnM view
    - 11.1.2.4.1 Right to win
    - 11.1.2.4.2 Strategic choices
    - 11.1.2.4.3 Weaknesses and competitive threats
- 11.1.3 DANAHER CORPORATION
  - 11.1.3.1 Business overview
  - 11.1.3.2 Products offered
  - 11.1.3.3 Recent developments
    - 11.1.3.3.1 Deals
  - 11.1.3.4 MnM view
    - 11.1.3.4.1 Right to win
    - 11.1.3.4.2 Strategic choices
    - 11.1.3.4.3 Weaknesses and competitive threats
- 11.1.4 AGILENT TECHNOLOGIES
  - 11.1.4.1 Business overview
  - 11.1.4.2 Products offered
  - 11.1.4.3 Recent developments
    - 11.1.4.3.1 Product launches
    - 11.1.4.3.2 Deals
    - 11.1.4.3.3 Expansions
  - 11.1.4.4 MnM view
    - 11.1.4.4.1 Right to win
    - 11.1.4.4.2 Strategic choices
    - 11.1.4.4.3 Weaknesses and competitive threats
- 11.1.5 F. HOFFMANN-LA ROCHE LTD.
  - 11.1.5.1 Business overview
  - 11.1.5.2 Products offered
  - 11.1.5.3 Recent developments
    - 11.1.5.3.1 Product launches
    - 11.1.5.3.2 Deals
    - 11.1.5.3.3 Expansions
  - 11.1.5.4 MnM view
    - 11.1.5.4.1 Right to win
    - 11.1.5.4.2 Strategic choices
    - 11.1.5.4.3 Weaknesses and competitive threats
- 11.1.6 METTLER TOLEDO
  - 11.1.6.1 Business overview
  - 11.1.6.2 Products offered
  - 11.1.6.3 Recent developments
    - 11.1.6.3.1 Product launches
    - 11.1.6.3.2 Deals
- 11.1.7 REVVITY, INC.
  - 11.1.7.1 Business overview
  - 11.1.7.2 Products offered
  - 11.1.7.3 Recent developments
    - 11.1.7.3.1 Product launches
    - 11.1.7.3.2 Deals
- 11.1.8 EPPENDORF SE
  - 11.1.8.1 Business overview
  - 11.1.8.2 Products offered
  - 11.1.8.3 Recent developments
    - 11.1.8.3.1 Product launches
    - 11.1.8.3.2 Deals
- 11.1.9 BECTON, DICKINSON AND COMPANY
  - 11.1.9.1 Business overview
  - 11.1.9.2 Products offered
  - 11.1.9.3 Recent developments
    - 11.1.9.3.1 Product launches and approval
    - 11.1.9.3.2 Deals
    - 11.1.9.3.3 Expansions
- 11.1.10 WATERS CORPORATION
  - 11.1.10.1 Business overview
  - 11.1.10.2 Products offered
  - 11.1.10.3 Recent developments
    - 11.1.10.3.1 Deals
    - 11.1.10.3.2 Expansions
- 11.1.11 SIEMENS HEALTHINEERS
  - 11.1.11.1 Business overview
  - 11.1.11.2 Products offered
  - 11.1.11.3 Recent developments
    - 11.1.11.3.1 Product launches
    - 11.1.11.3.2 Expansions
- 11.1.12 ABBOTT LABORATORIES
  - 11.1.12.1 Business overview
  - 11.1.12.2 Products offered
- 11.1.13 BIOMERIEUX
  - 11.1.13.1 Business overview
  - 11.1.13.2 Products offered
- 11.1.14 HAMILTON COMPANY
  - 11.1.14.1 Business overview
  - 11.1.14.2 Products offered
  - 11.1.14.3 Recent developments
    - 11.1.14.3.1 Product launches
    - 11.1.14.3.2 Deals
- 11.1.15 HUDSON ROBOTICS
  - 11.1.15.1 Business overview
  - 11.1.15.2 Products offered
  - 11.1.15.3 Recent developments
    - 11.1.15.3.1 Deals
11.2 OTHER COMPANIES
- 11.2.1 GILSON, INC.
- 11.2.2 BMG LABTECH
- 11.2.3 FESTO AG & CO. KG
- 11.2.4 AURORA BIOMED INC.
- 11.2.5 HIGHRES BIOSOLUTIONS
- 11.2.6 OPENTRONS LABWORKS INC.
- 11.2.7 PEAK ANALYSIS AND AUTOMATION
- 11.2.8 QIAGEN N.V.
- 11.2.9 LABVANTAGE SOLUTIONS, INC.
- 11.2.10 BIO-RAD LABORATORIES, INC.
- 11.2.11 LABWARE
- 11.2.12 SYSMEX CORPORATION
- 11.2.13 UNIVERSAL ROBOTS
- 11.2.14 AB CONTROLS, INC.
- 11.2.15 AUTOMATA
- 11.2.16 SPT LABTECH
- 11.2.17 BIOSERO, INC.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS